# CLAUDE DEEP RESEARCH REPORT - SHORGAN-BOT
## Week of October 26, 2025
### Generated: 2025-10-26 at 05:04 PM ET
### Model: Claude Opus 4.1 with Extended Thinking (Anthropic)
### Portfolio Value: $103,577.01

---

# SHORGAN-BOT WEEKLY DEEP RESEARCH REPORT
**Date:** October 26, 2025 | **Week 8** | **Portfolio Value:** $103,577.01

## 1. CATALYST CALENDAR (October 27 - November 25)

### IMMEDIATE CATALYSTS (Next 7 Days):
- **WOLF** - Q3 Earnings: October 28 (Tuesday) AMC
- **ARQT** - Phase 2 ARQ-252 Data Update: October 30 (Thursday) at EADV Congress
- **FUBO** - Q3 Earnings: November 1 (Friday) BMO
- **INCY** - Opzelura Expanded Label Decision: By October 31

### MEDIUM-TERM CATALYSTS (8-30 Days):
- **IONQ** - Q3 Earnings: November 6 (Wednesday) AMC
- **RGTI** - Q3 Earnings: November 8 (Friday) AMC
- **MFIC** - Q3 Earnings: November 12 (Tuesday) AMC
- **SNDX** - Q3 Earnings: November 14 (Thursday) BMO
- **DAKT** - Q2 FY25 Earnings: November 20 (Wednesday) AMC

## 2. CURRENT PORTFOLIO REVIEW

### HIGH-CONVICTION HOLDS:
- **RGTI** (Long 27 shares, +153%): HOLD through earnings. Quantum momentum intact, but trim 50% pre-earnings
- **IONQ** (Short 200 shares, +19%): HOLD short. Overvaluation thesis playing out perfectly
- **INCY** (Long 61 shares, +9%): HOLD for FDA catalyst

### POSITIONS TO EXIT:
- **SPY** (Long 18 shares): SELL - Capital better deployed in high-beta catalysts
- **UNH** (Long 42 shares): SELL - Low volatility, minimal catalyst upside
- **CVX** (Short 93 shares): COVER - Oil stabilizing, limited downside

### POSITIONS TO MONITOR:
- **WOLF**: Binary earnings play - extreme volatility expected
- **ARQT**: Phase 2 data critical - potential 40%+ move
- **FUBO**: Make-or-break earnings on profitability path

## 3. NEW OPPORTUNITIES ANALYSIS

### TOP LONG OPPORTUNITIES:

**1. SMCI - Super Micro Computer**
- Catalyst: Delayed 10-K filing due Oct 30, oversold on accounting concerns
- Setup: $45 support held, RSI oversold at 28
- Risk/Reward: $44 stop, $58 target (1:3.2 R/R)

**2. NKLA - Nikola Corporation**
- Catalyst: Q3 deliveries report Nov 1, hydrogen momentum building
- Setup: Breaking $6.50 resistance on volume
- Risk/Reward: $6.20 stop, $8.50 target (1:7.7 R/R)

### TOP SHORT OPPORTUNITIES:

**3. LCID - Lucid Group**
- Catalyst: Q3 deliveries miss expected Nov 3
- Setup: Failed at $4 resistance, declining volumes
- Risk/Reward: $4.10 stop, $3.20 target (1:2.3 R/R)

**4. CVNA - Carvana**
- Catalyst: Q3 earnings Nov 7, margin compression expected
- Setup: Parabolic move exhausted at $260
- Risk/Reward: $265 stop, $220 target (1:9 R/R)

### OPTIONS STRATEGY:

**5. ARQT Call Debit Spread**
- Binary event: Phase 2 data October 30
- Strategy: Buy Nov 1 $22.50C, Sell Nov 1 $25C
- Cost: $0.85 debit, Max gain: $1.65 (194% return)

## 4. EXACT ORDER BLOCKS

```
Action: sell
Ticker: SPY
Shares: 18
Order type: limit
Limit price: $677.50
Time in force: DAY
Intended execution date: 2025-10-27
Catalyst date: N/A
Stop loss: N/A
Target price: N/A
One-line rationale: Freeing capital for higher-beta catalyst plays
```

```
Action: sell
Ticker: UNH
Shares: 42
Order type: limit
Limit price: $363.00
Time in force: DAY
Intended execution date: 2025-10-27
Catalyst date: N/A
Stop loss: N/A
Target price: N/A
One-line rationale: Low volatility healthcare exit for catalyst redeployment
```

```
Action: buy_to_close
Ticker: CVX
Shares: 93
Order type: limit
Limit price: $155.80
Time in force: DAY
Intended execution date: 2025-10-27
Catalyst date: N/A
Stop loss: N/A
Target price: N/A
One-line rationale: Oil stabilizing, covering profitable short to redeploy
```

```
Action: buy
Ticker: SMCI
Shares: 500
Order type: limit
Limit price: $46.50
Time in force: GTC
Intended execution date: 2025-10-28
Catalyst date: 2025-10-30
Stop loss: $44.00
Target price: $58.00
One-line rationale: Oversold on accounting FUD, 10-K filing catalyst imminent
```

```
Action: sell_to_open
Ticker: LCID
Shares: 1000
Order type: limit
Limit price: $3.85
Time in force: GTC
Intended execution date: 2025-10-28
Catalyst date: 2025-11-03
Stop loss: $4.10
Target price: $3.20
One-line rationale: Q3 delivery miss expected, production challenges persist
```

```
Action: sell_to_open
Ticker: CVNA
Shares: 100
Order type: limit
Limit price: $255.00
Time in force: GTC
Intended execution date: 2025-10-28
Catalyst date: 2025-11-07
Stop loss: $265.00
Target price: $220.00
One-line rationale: Parabolic exhaustion, Q3 margin compression catalyst
```

```
Action: buy_to_open
Ticker: ARQT
Option: CALL $22.50 2025-11-01
Order type: limit
Limit price: $0.85
Time in force: DAY
Intended execution date: 2025-10-28
Catalyst date: 2025-10-30
Stop loss: 50% of premium
Target price: $2.50 (contract value)
One-line rationale: Binary Phase 2 data event with 200%+ upside potential
```

```
Action: sell_to_open
Ticker: ARQT
Option: CALL $25.00 2025-11-01
Order type: limit
Limit price: $0.40
Time in force: DAY
Intended execution date: 2025-10-28
Catalyst date: 2025-10-30
Stop loss: N/A (part of spread)
Target price: N/A
One-line rationale: Capping upside on call spread for defined risk
```

```
Action: sell
Ticker: RGTI
Shares: 14
Order type: limit
Limit price: $39.00
Time in force: GTC
Intended execution date: 2025-10-29
Catalyst date: 2025-11-08
Stop loss: N/A
Target price: N/A
One-line rationale: Trimming 50% of quantum winner ahead of volatile earnings
```

## 5. RISK AND LIQUIDITY CHECKS

### POSITION SIZING:
- Maximum single position: 15% of portfolio ($15,536)
- Binary event positions: 5% max ($5,179)
- Total short exposure: Currently 31% â†’ Target 35%

### LIQUIDITY ANALYSIS:
- All new positions have >1M daily volume
- Exit liquidity verified for all holdings
- Options positions sized for liquid strikes only

### PORTFOLIO RISK METRICS:
- Current Beta: 1.42
- Target Beta: 1.65 (post-rebalancing)
- Max drawdown tolerance: 15%
- Stop losses on all new positions

## 6. MONITORING PLAN

### DAILY MONITORING (Pre-Market):
- **October 28**: WOLF earnings reaction
- **October 30**: ARQT Phase 2 data release
- **November 1**: FUBO earnings, NKLA deliveries

### TECHNICAL TRIGGERS:
- **SMCI**: Add on break above $48 with volume
- **LCID**: Cover if holds above $4.10 for 2 days
- **CVNA**: Add to short on rejection at $260

### PROFIT TAKING RULES:
- Take 50% profits at 2:1 R/R achieved
- Trail stops at 20% on positions >30% gain
- Full exit on catalyst completion + 2 days

### CATALYST TRACKING:
- Set alerts for all earnings dates
- Monitor biotech conference presentations
- Track option flow for unusual activity

**CONVICTION SCORE: 9/10** - Multiple high-probability catalysts aligned with strong technical setups. The combination of earnings season volatility and binary biotech events creates an ideal environment for SHORGAN-BOT's aggressive catalyst-driven strategy.